What are the potential side effects and treatment considerations for a patient taking Metoprolol (beta-blocker) 50 mg long acting for hypertension or heart failure?

Metoprolol 50 mg Long-Acting: Side Effects and Management

Common Side Effects

The most frequently reported side effects of metoprolol include tiredness and dizziness (occurring in approximately 10% of patients), bradycardia and shortness of breath (approximately 3% of patients), and depression (approximately 5% of patients). 1

Cardiovascular Side Effects

• Bradycardia (heart rate <50 bpm) occurs in approximately 3% of patients and may require dose reduction if symptomatic 1
• Hypotension is usually asymptomatic but can cause dizziness, lightheadedness, or blurred vision 2
• Cold extremities and arterial insufficiency (Raynaud-type) occur in approximately 1% of patients 1
• Peripheral edema and congestive heart failure have been reported in about 1% of patients 1

Central Nervous System Effects

• Tiredness and dizziness are the most common, affecting 10% of patients 1
• Depression occurs in approximately 5% of patients 1
• Mental confusion, short-term memory loss, headache, nightmares, and insomnia have been reported 1

Respiratory Effects

• Bronchospasm and wheezing occur in approximately 1% of patients, particularly concerning in those with underlying reactive airway disease 1
• Dyspnea has been reported 1

Gastrointestinal Effects

• Diarrhea occurs in approximately 5% of patients 1
• Nausea, dry mouth, gastric pain, constipation, and vomiting are common occurrences 1

Other Side Effects

• Pruritus or rash occur in approximately 5% of patients 1
• Blurred vision, tinnitus, and musculoskeletal pain have been reported 1
• Rare reports include reversible alopecia, weight gain, and sexual dysfunction 1

Management of Side Effects

Bradycardia Management

If heart rate falls below 50 bpm with worsening symptoms (dizziness, lightheadedness, or syncope), halve the metoprolol dose immediately. 2

• Review other heart rate-slowing medications (digoxin, amiodarone, diltiazem, verapamil) and consider discontinuation 2
• Obtain an electrocardiogram to exclude heart block 2
• If heart rate remains <45 bpm consistently, hold the dose for 12 hours 3
• Seek specialist advice if symptoms persist after dose reduction 2

Hypotension Management

Asymptomatic low blood pressure does not require treatment changes. 2

For symptomatic hypotension (dizziness, lightheadedness, confusion):

• First, reconsider need for nitrates, calcium-channel blockers, and other vasodilators—reduce or stop these medications if possible 2
• Second, if no signs of congestion are present, consider reducing diuretic dose 2
• Third, if above measures fail, temporarily reduce metoprolol dose by 50% 2
• Never reduce metoprolol first—address other vasodilators and volume status before adjusting beta-blocker 2

Worsening Heart Failure

If increasing congestion develops (dyspnea, fatigue, edema, weight gain >1.5-2.0 kg over 2 days), increase diuretic dose first. 2

• Only halve metoprolol dose if increasing diuretic does not resolve congestion 2
• Monitor daily weights and adjust diuretics accordingly 2
• Rarely necessary to stop metoprolol completely 2

Fatigue Management

Marked fatigue typically resolves spontaneously within several weeks without treatment. 2

• If severe enough to limit function, halve the metoprolol dose 2
• Review patient in 1-2 weeks after dose reduction 2
• Consider reducing diuretic dose if volume depletion is suspected 2
• Discontinue only if fatigue is accompanied by evidence of peripheral hypoperfusion 2

Bronchospasm Management

Metoprolol should generally be avoided in patients with active asthma or severe reactive airway disease. 1

• If bronchospasm develops, ensure beta-2 agonist bronchodilators are readily available 1
• Use the lowest possible dose and consider dividing into three times daily dosing to avoid higher peak plasma levels 1
• Discontinue if severe bronchospasm occurs 1

Critical Warnings

Never Abruptly Discontinue

Abrupt discontinuation of metoprolol can cause severe exacerbation of angina, myocardial infarction, ventricular arrhythmias, and has been associated with 50% mortality in one study. 1, 2

• When discontinuation is necessary, taper gradually over 1-2 weeks 1
• Monitor closely for worsening angina or ischemia during tapering 1
• Beta-blocker withdrawal increases 1-year mortality risk 2.7-fold compared to continuous use 3

Contraindications Requiring Immediate Discontinuation

• Signs of decompensated heart failure or low output state 1, 2
• Second or third-degree heart block without a functioning pacemaker 1
• Cardiogenic shock 1
• Severe bradycardia (<50 bpm) with hemodynamic compromise 2

Drug Interactions to Monitor

• Other heart rate-slowing drugs (digoxin, amiodarone, diltiazem, verapamil) increase bradycardia risk 2
• Calcium channel blockers (especially diltiazem and verapamil) should be discontinued due to negative inotropic effects 2
• NSAIDs may reduce antihypertensive efficacy 2

Overdose Management

In metoprolol overdose, expect bradycardia, hypotension, bronchospasm, and potential cardiovascular collapse. 1, 4

• No specific antidote exists 1
• For hypotension: administer vasopressors (norepinephrine or dopamine) 1
• For bronchospasm: administer beta-2 agonists and/or theophylline 1
• For cardiac failure: consider dobutamine, isoproterenol, or glucagon 1
• Advanced cases may require intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy 4
• Gastric lavage and activated charcoal if recent ingestion 4

Special Populations

Diabetes

Beta-blockers may mask tachycardia associated with hypoglycemia, though dizziness and sweating remain detectable. 1

• Monitor blood glucose more frequently 1
• Educate patients about non-cardiac hypoglycemia symptoms 1

Pheochromocytoma

Metoprolol must only be used in combination with an alpha-blocker, and only after the alpha-blocker has been initiated. 1